Does obesity play a role in whether or not people undergo various types of cancer screening? The simple answer is "yes." The more nuanced answer says it depends on the individual's gender, race and type of cancer screening.

The hormone estrogen is well-known for driving breast cancer. Researchers are now finding that estrogen-blocking medications, which are commonly used to help prevent a recurrence of the disease, may have uses in other cancers as well.

Do walnuts fight off cancer? A recent Harvard Medical School study showed that walnuts have inhibitory effects upon colorectal cancer in mice.

Women with recurrent ovarian cancer have very few treatment options. That's about to change. In the near future, women may have vaccines custom made for them to help their immune systems attack the cancer.

As with a number of other health recommendations, guidelines regarding prostate cancer screenings have been all over the place lately. What's a guy to think? More importantly, what's he to do?

Treating esophageal cancer is rigorous. Surgery can involve not just the throat, but the chest and abdomen. So how's life after such extensive treatment? Researchers wanted to know and found out.

Developing new drugs takes years of research and costs millions of dollars. That's why scientists often look at the existing pool of pharmaceutical medications as possible solutions for a wide range of diseases.

Progress is being made on most oncology fronts. Unfortunately, brain metastasis remains something medicine hasn't touched in an effective way. Researchers may have found a new opening in resolving the greatest challenge women with advanced breast cancer face.

More and more, we're hearing about unintended consequences and side effects of medicines that have been on the market sometimes for years. Women who have beaten breast cancer can bask in new findings about a medication most of them take.

While the prevalence of a number of cancers is declining, some types are on the rise. The incidence of one of the more difficult forms of liver cancer to treat has tripled over the past 30 years. And researchers are beginning to know why.